William D. Turner is Chief Regulatory Officer of Vera Therapeutics, Inc.. Currently has a direct ownership of 22,500 shares of VERA, which is worth approximately $637,200. The most recent transaction as insider was on Dec 15, 2025, when has been sold 10,000 shares (Class A Common Stock) at a price of $50.08 per share, resulting in proceeds of $500,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.5K
0% 3M change
n/a 12M change
Total Value Held $637,200

William D. Turner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2025
SELL
Open market or private sale
$500,800 $50.08 p/Share
10,000 Reduced 30.77%
22,500 Class A Common Stock
Dec 15 2025
BUY
Exercise of conversion of derivative security
$155,300 $15.53 p/Share
10,000 Added 23.53%
32,500 Class A Common Stock
Dec 08 2025
SELL
Open market or private sale
$453,100 $45.31 p/Share
10,000 Reduced 30.77%
22,500 Class A Common Stock
Dec 08 2025
BUY
Exercise of conversion of derivative security
$155,300 $15.53 p/Share
10,000 Added 23.53%
32,500 Class A Common Stock
Dec 03 2025
SELL
Open market or private sale
$400,000 $40.0 p/Share
10,000 Reduced 30.77%
22,500 Class A Common Stock
Dec 03 2025
BUY
Exercise of conversion of derivative security
$155,300 $15.53 p/Share
10,000 Added 23.53%
32,500 Class A Common Stock
Feb 18 2025
BUY
Grant, award, or other acquisition
-
22,500 Added 50.0%
22,500 Class A Common Stock

Also insider at

SRRA
Sierra Oncology, Inc. Healthcare
WDT

William D. Turner

Chief Regulatory Officer
San Mateo, CA

Track Institutional and Insider Activities on VERA

Follow Vera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERA shares.

Notify only if

Insider Trading

Get notified when an Vera Therapeutics, Inc. insider buys or sells VERA shares.

Notify only if

News

Receive news related to Vera Therapeutics, Inc.

Track Activities on VERA